U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07719972) titled 'Universal Newborn Screening For Sickle Cell Disease In Mozambique' on July 17.
Brief Summary: The overarching goal of this study is to evaluate the feasibility of a new methodology that combines three multi-level implementation strategies to optimize the population-level uptake of essential evidence-based, standard of care treatments for infants with sickle cell disease (SCD) in low-resource settings. The study will be done in Mozambique.
Study Start Date: Aug., 2026
Study Type: INTERVENTIONAL
Condition:
Sickle Cell Disease
Intervention:
OTHER: Point-of-care testing (POCT) -Patient participants
Infants will be screened for Si...